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Abstract: 
The practice of tight glycemic control using an intravenous insulin infusion has been adopted in many clinical 
settings, and although beneficial patient outcomes have been clearly documented, the therapy poses potential 
risks to patient safety related to hypoglycemia and increases nursing workload. This article examines these 
issues through a review of current research on tight glycemic protocols. Strategies for nurse leaders are 




The stress of critical illness often leads to hyperglycemia, even in patients without a history of diabetes, and 
hyperglycemia in critically ill patients has been associated with an increased infection rate and an impaired 
immune response.1-6 An increase in catecholamine release, hepatic gluconeogenesis, or relative insulin 
resistance may be the cause of hyperglycemia in critically ill patients.7 Other causes may include the use of 
corticoid steroids, vasopressors, or total parental nutrition.2 Certain medical conditions also increase the 
risk of stress-induced hyperglycemia including sepsis, acute myocardial infarction, stroke, surgery, and 
trauma.4 
  
Impaired glycemic control has been associated with adverse outcomes in patients with myocardial 
infarction and acute coronary syndrome, stroke, postoperative complications, and trauma. Krinsley 4 found 
higher mortality rates for patients who did not maintain glycemic control while in the intensive care unit 
(ICU). These and similar findings have prompted more research to determine whether controlling blood 
glucose with an insulin infusion leads to better patient outcomes.1,4,8 In a study of 1,548 surgical intensive 
care patients, Van den Berghe and colleagues 6 found that in-hospital mortality was decreased by 34% with 
the use of an intravenous (IV) insulin protocol. Similar research found that use of a continuous insulin 
infusion to control glucose levels decreased morbidity and reduced predicted mortality for diabetic patients 
who had cardiovascular surgery.1 
  
The American Association of Clinical Endocrinologists advocates the use of insulin infusions to maintain 
blood glucose levels between 80 and 110 mg/dL in critically ill patients.9 The American Diabetes 
Association's (ADA's) 2006 position statement also recommends tight glycemic control, with the goal of 
maintaining blood glucose level at less than 110 mg/dL for critical care patients.10 
  
The critical care nurse is responsible for the maintenance of tight glycemic control, which involves 
following an insulin protocol, usually consisting of preprinted physician order sets that allow the nurse to 
control the patient's blood glucose level with minimal additional physician orders. Glycemic control is 
  
generally achieved through the use of a continuous IV insulin infusion. Although the research literature 
clearly shows that tight glycemic control is beneficial, the therapy is not without risk. The Institute for Safe 
Medication Practices lists insulin as a high-alert medication because of the risk of significant patient harm 
in case of error.11 The primary risk to patient safety in administering insulin intravenously is 
hypoglycemia. Intravenous insulin has a rapid onset of action and may cause severe hypoglycemia, which, 
if untreated, can result in neurological impairment or death.7 The insulin infusion is adjusted based on 
blood glucose testing done at the bedside, which facilitates immediate adjustments of the insulin infusion, 
but requires time and attention from the nurse. 
The practice of tight glycemic control has been adopted in many clinical settings, and although beneficial 
patient outcomes have been clearly documented, the therapy poses potential risks to patient safety related to 
hypoglycemia and increases nursing workload. This article examines these issues through a review of 
current research on tight glycemic protocols. Strategies for nurse leaders are provided to improve patient 




METHODS   
The Matrix method by Garrard 12 was used to conduct a systematic review of published studies. The 
review was conducted with various databases. Only articles from peer-reviewed medical and nursing 
journals, available in English, and published from 2001 to 2007 were considered. The search was also 
limited to research studies on adult patients, in hospital ICUs, and who experienced hyperglycemia and 
were treated with a continuous insulin infusion. A total of 57 articles were examined, and 7 met all the 
criteria. A snowball technique was used to search references from the articles to identify additional 
information sources.12 Two additional articles were found that reported results from a study already 
included in the matrix, for a total of 9 articles reporting findings from 7 studies on tight glycemic control by 
an insulin infusion. 
  
Information was also sought about hypoglycemia, nurses' workload, and patient safety as it related to tight 
glycemic control. Again, databases were searched for articles in various nursing and medical journals from 
2001 to 2007. Search terms included tight glycemic control with qualifiers of hypoglycemia, patient safety, 
nurses' workload, and accuracy of bedside glucose testing. This search resulted in the identification of 6 




RESULTS   
The studies on tight glycemic control included 1 randomized controlled trial, 2 comparative studies, 2 with 
combined prospective/retrospective designs, 1 prospective observational, and 1 descriptive study. Sample 
sizes ranged from 20 to 1,548 subjects. Most subjects were male; ethnicity was not reported consistently 
enough for comparison. The studies were conducted at international sites and a variety of ICU settings. 
Additional information is provided in Table 1. Three articles examined blood glucose testing, and 3 studies 
examined hypoglycemia and/or nurses' workload. 
 
 




Blood Glucose Measurement   
Blood glucose levels must be measured frequently to ensure glycemic control. All of the studies 
examined used bedside glucose monitoring devices (point of care), but the sample source differed among 
studies. One study obtained blood samples from an arterial line exclusively, 2 studies obtained blood 
from either an arterial line or finger stick (capillary sample), and 3 studies used finger stick only. 
  
Obtaining blood glucose results from the laboratory is not feasible for management of insulin infusions 
because of both the cost and the time lapse between sample collection and availability of results, but it is 
considered the most accurate test and may be considered the criterion standard by many. Because 
laboratory testing is not practical or cost-effective, bedside testing is used for rapid reporting of blood 
sugar results for insulin infusion adjustments. According to the literature, the best practice in bedside 
testing is the blood gas/chemistry analyzer, but not all hospitals may have these machines available at the 
bedside. Two studies found that capillary testing with a bedside glucometer was correlated with 
laboratory findings.13,14 Research by Kanji and colleagues 15 did not support these findings, but the 
treatment groups within the study differed significantly from those in the other studies. More research is 
needed in this area, but based on current evidence, it is reasonable to recommend that blood glucose 
monitoring be performed at the bedside, with arterial blood if possible. If an arterial line is not available, 
then capillary glucose levels should be checked. For patients receiving vasoactive drugs, with moderate 
peripheral edema, or with abnormal hematocrit or carbon dioxide levels, an arterial blood sample should 
be obtained.14,15 Regardless of the source of blood for bedside testing, the results should be confirmed 
by laboratory results at least once a day. If there is any question of the validity of the bedside results, 




Hypoglycemia   
The most significant risk to patient safety when the blood glucose level is controlled within narrow 
parameters is hypoglycemia. The ADA defines hypoglycemia as a blood glucose level of 70 mg/dL or 
less and recommends treatment with glucose or carbohydrate and a recheck in 15 minutes.10   
Hypoglycemia can develop quickly. Symptoms include shakiness, dizziness, sweating, hunger, pale skin, 
behavioral changes, and confusion.16 Many of these symptoms may be difficult to recognize quickly in 
critically ill patients, especially if the patient is sedated and mechanically ventilated. Hypoglycemia that 
is not treated quickly can lead to severe neurological consequences including confusion, agitation, coma, 
and death.7 
  
Although the normal fasting blood glucose level for an adult is 70 to 110 mg/dL,17 none of the studies 
reviewed here used 70 mg/dL as the definition of hypoglycemia (see Table 1). The lack of consistent 
definitions of hypoglycemia creates difficulty in comparing the incidence of hypoglycemia across 
studies. A total of 4 studies used a hypoglycemic threshold less than the ADA-recommended level of 70 
mg/dL.10 Clearly, the incidence of hypoglycemia will increase as the defined blood value for 
hypoglycemia increases. However, among the studies reviewed here, the one with the lowest defining 
value for hypoglycemia (<40 mg/dL) found a high incidence of hypoglycemia, indicating a problem in 
maintaining optimal glycemic control in study patients. 
  
The reported incidence of hypoglycemia varied from 1.36% to 6.9% (see Table 1).1-5,18,19 This 
variation in rate can be attributed to inconsistent definitions of hypoglycemia.   
Few studies have examined the efficacy and safety of insulin protocols for critically ill patients. One such 
study conducted with 30 ICU patients found that 60% of the patients had at least 1 hypoglycemic event, 
and 37% of patients required a dextrose bolus.19 The efficacy of the insulin protocol was low, with 
blood glucose levels remaining in the target range of 81 to 110 mg/dL only 42% of the total time the 
protocol was implemented. Most blood glucose levels were managed within the protocol standards, 
resulting in an adherence rate of 71%. Justification for protocol deviations was provided in only 5% of 
the cases and included alterations in nutrition or patient transport. Van den Berghe and colleagues 18 also 
examined reasons for hypoglycemia and found that 62% of hypoglycemic events were related to an 
interruption of enteral feeding without appropriate adjustments in insulin rate infusion. 
 
 
Figure 1. Target glucose and hypoglycemia ranges. 
 
When examining patient safety issues regarding insulin infusions and tight glycemic control, it is important 
to consider not only at what blood level hypoglycemia is defined, but also how the target glucose range is 
defined. The studies of tight glycemic control reviewed here had different target glucose ranges (see Figure 
1). Also, in most of the studies, there was a gap between the lower level of target blood glucose and the 
upper range of hypoglycemia. Some studies defined this area as low, whereas others left it undefined. When 
a study patient had a blood glucose result that fell into this area, the patient may have been experiencing 
clinical signs of hypoglycemia that were not reported as a hypoglycemic event according to the protocol. 
 
Considering that greater than half of the studies had a gap that fell below the ADA definition of 
hypoglycemia as a blood sugar level of less than 70 mg/dL,10 it is likely that the incidence of clinical 
hypoglycemia was higher than reported in these studies. In addition, insulin protocols that have an 
undefined gap between the lower level of target blood glucose and defined hypoglycemia may pose a 
safety risk to patients, as clinical hypoglycemia may occur that is not adequately addressed by the 
protocol. Further research is needed to examine the impact of the use of IV insulin protocols on patient 





Insulin Protocols and Nursing Workload   
The American College of Endocrinology and ADA consensus statement on impatient diabetes glycemic 
control states, "Nurses are essential for successful implementation of protocols, orders sets, more 
intensive glucose monitoring, and educational programs targeting enhanced glycemic control."20
(p1958)
 
The task force also notes that the time and effort required of nurses to implement tight glycemic control 
  
can overburden the nursing system. 
Safe implementation of an insulin infusion protocol requires frequent blood glucose monitoring and 
calculation and titration of the insulin infusion rate, which increases the bedside nurse's workload. Only 1 
study of tight glycemic control specifically addressed the increased nursing workload associated with 
managing an insulin protocol. Krinsley 4 found that initiation of the IV insulin protocol and the increased 
workload associated with its use did not cause a significant change in staffing requirements in the ICU. 
However, examination of staffing requirements at the unit level may be too broad of a measure to 
accurately assess the increased workload placed on an individual nurse managing an insulin protocol. 
 
 
Figure 2. Frequency of glucose testing per protocol. 
Two factors that indicate the increase in nurses' workload include the number of blood glucose checks 
required in a 24-hour period and the degree of difficulty in calculating the proper insulin infusion rate. The 
studies examined here prescribed the minimal and maximum numbers of blood glucose tests to be 
completed in a set period (see Figure 2). The minimum number of tests in a 24-hour period was 6 (every 4 
hours), and the maximum number of tests was 48 (every 30 minutes). One study did not have any 
variability in blood glucose measurements as the protocol required hourly checks only.4 The level of 
variability in potential number of glucose checks demonstrated by most studies makes nursing workload 
assessments and staffing planning very difficult, as a patient with labile blood sugars will produce a much 
greater nursing workload than a patient with stable blood sugar levels requiring less frequent monitoring 
and fewer insulin drip titrations. 
 
The degree of difficulty in calculating the proper insulin infusion rate is subjective, and it can vary from 
independent calculations conducted by the nurse, to reading a titration table or chart, to inserting 
numbers into a bedside device, such as a Glucommander, or computer program that automatically 
calculates insulin drip titrations. Two of the insulin protocols had simple tables that indicated what the 
  
rate of insulin should be for a specific blood glucose level.1,4 Van den Berghe 21 insulin protocol also 
had a simple table, but used indefinite terms such as approaching normal or falling steeply to direct the 
nurse in insulin drip management. The use of vague terms leaves much room for interpretation and 
individual discretion by the nurse in blood glucose management. Kanji and colleagues 2 modified a 
simple titration table to include the previous blood glucose level. Users were directed to the new insulin 
infusion rate by locating the current and previous blood glucose level on the chart and following titration 
directions. This method adds another step to the process and possibly introduces error, but allows for 
more individual treatment of patients. 
Osburne and colleagues 5 used the Columnar Insulin Dosing Chart. Blood glucose ranges are divided 
into 3 large groups of hyperglycemic, within target, and hypoglycemic. The instructions on the table 
indicate in which of 10 columns the correct insulin infusion rate is found, and the nurse is directed to a 
left or right column according to either an increase or decrease in the patient's blood glucose level from 
the prior test. The Columnar system is complicated, but aided by the use of color coding to define the 
differing blood glucose ranges. There is more opportunity for error in reading this table, and its use may 
require additional time from the bedside nurse. However, the protocol allows for more precise 
adjustments to the insulin infusion. 
  
The most complicated insulin infusion algorithm among the studies consisted of a table with blood 
glucose ranges on one side and directions for insulin titrations. A decrease in blood glucose directed the 
nurse to decrease an infusion by one-third or two-thirds of the previous rate.3 The use of fractions to 
calculate a current drip rate must be done meticulously, can be time consuming, and is overall not a user-
friendly approach to insulin drip management. In addition, it requires an infusion pump that can 
administer a drip rate to the 10th decimal, which can also potentially increase the risk for error. 
  
Two studies examined nurses' perspectives on the impact of tight glycemic control on workload. The first 
surveyed 60 nurses using an insulin protocol in which the insulin infusion rate was determined from a 
simple table, with no calculations required.22 Deviations from the protocol were high, with 
approximately 75% of all blood glucose measurements associated with a protocol deviation, averaging to 
greater than 9 per patient. This number is quite high, considering that each deviation from the protocol 
involves additional steps in the glucose management process and may also require a call to the patient's 
physician. One possible explanation for the high percentage of protocol deviations may be due to nurses' 
distrust of the effectiveness and safety of the protocol. Nearly a third of the nurses (32%) disagreed that 
the protocol was effective in preventing patient hypoglycemia; therefore, they may have initiated 
protocol deviations if they thought the insulin protocol was too aggressive in lowering blood glucose and 
placed the patient at an increased risk for hypoglycemia. 
  
A majority of the nurses surveyed (70%) indicated that the protocol increased their workload, primarily 
because of the increased frequency of blood glucose measurements.22 Difficulty in using the protocol 
was also noted. Eighteen percent of nurses reported difficulty in determining the appropriate insulin 
infusion rate, and 32% reported the algorithm as an obstacle to glycemic control because it was either too 
complicated or did not adequately control blood glucose levels. The reported level of difficulty in 
administering the protocol is concerning, as 60% of the nurses surveyed had been in practice for 5 or 
  
more years, and the largest percentage of nurses (41%) surveyed had greater than 10 years of experience. 
In a similar study, 66 nurses responded to survey questions about their perceptions of insulin protocols 
on nursing workload.23 Although nurses agreed that tight glycemic control is an important part of patient 
care, over 60% reported concerns about work effort through narrative comments, with many reporting it 
was too much work (24%) or took too much time (44%). Some nurses (15%) reported that the protocol 
was difficult to administer on two patients simultaneously. In this study, 90% of the blood glucose 
monitoring was performed by nurses. 
  
The research reviewed here reveals several factors that increase nursing workload. Blood glucose 
monitoring every 30-60 minutes adds considerably to nurses' workload, especially in the busy ICU 
environment. Difficulty in determining the correct dose of insulin also clearly affects nurses' workload. 
Reading complicated tables, protocols, and performing math calculations increase the time needed to 




Implications for Nurse Leaders   
The benefits of tight glycemic control need to be weighed against the risk of hypoglycemic events. To 
achieve the best outcomes for patients, a multidisciplinary approach to implementing tight glycemic 
control is helpful. A standardized order set, standardized insulin infusion concentration, and adequate 
number of glucose testing devices at the bedside can increase patient safety and reduce nursing 
workload. As the use of insulin protocols increases, nurses may find that there are an inadequate number 
of glucometers available to meet the needs of several patients receiving insulin infusions. In a study that 
examined barriers to insulin infusion protocols, Goldberg and Inzucchi 24 found that time spent 
searching for an available glucometer (increased workload) was one of the most common complaints by 
nurses. 
  
Administrative support of the practice of tight glycemic control is important to ensure adequate resources 
for nurses including education regarding protocol use and adequate staffing levels. Some of the reported 
difficulty in using glycemic control protocols may be reduced through the advent of more education for 
nursing staff. Goldberg and Inzucchi 24 found that nursing resistance to protocol implementation was 
decreased when education was provided that focused on the purpose and benefits of insulin protocols and 
addressed nurses' fears of causing hypoglycemia. Malesker and colleagues 22 also concluded that the 
high level of nonadherence to the protocol in their study may have resulted from inadequate nursing 
education and fears of hypoglycemia. Regarding staffing levels, nurse leaders should consider the 
increased demands on nursing time that insulin protocol management requires when making staffing 
assignments. Also, the use of support personnel, such as nurse aids or technicians, in performing bedside 
glucose checks should be maximized to aid in decreasing nursing workload. 
  
To address these concerns, nurse leaders should ensure that insulin protocols are selected that define 
hypoglycemia at levels that more closely follow the standards set by the ADA 10 and that adequate 
  
education is provided to nurses regarding the risks of hypoglycemia and the proper administration of 
insulin protocols. In addition, deviations from protocols should be monitored, and nursing input should 
be regularly sought regarding the feasibility and effectiveness of the protocols in maintaining glycemic 
control within safe parameters. Issues that affect either nursing workload or patient safety should be 
addressed and evaluated on a regular basis. The establishment of a quality control team designed to 




Directions for Future Research   
The benefits of tight glycemic control have been well documented. More research, however, is needed on 
the risk to patient safety related to hypoglycemia during tight glycemic control. Suggestions for further 
research and insulin protocol development include (1) the use of a standard definition of hypoglycemia to 
allow the true incidence of hypoglycemia to be determined and to facilitate comparisons across studies, 
(2) definitions for target blood sugar range and hypoglycemia that do not contain a gap where clinical 
hypoglycemia could occur that is not addressed by the protocol, (3) considerations for both nursing time 
and increased workload related to the frequency of blood glucose checks, and (4) the methods required to 
determine insulin infusion rate titrations. 
  
Nurse researchers should take the lead in further investigating tight glycemic control protocols. There are 
barriers in every institution to safe implementation of these protocols that may be best researched and 
addressed by nurses, as they are the primary providers who manage the protocols at the bedside and are 
able to provide a front-line assessment of their efficiency, effectiveness, and impact on both patient 
safety and nurse workload. The number of deviations from insulin protocol and the causes of those 
deviations should also be investigated further to aid in the refinement of protocols to maximize their 
effectiveness and patient safety. Staff education is essential for putting tight glycemic controls into 
practice, and the amount of education provided should be considered when protocol deviations are 
examined. Nurses' workload should be further studied to determine the impact of insulin protocols on 
staffing requirements. A key piece of this research should focus on the relationship between increased 
time demands caused by tight glycemic control and patient safety. 
  
Tight glycemic control is beneficial and safe for most patients. With some changes in practice aided by 
further research, the benefits of tight glycemic control can be realized by more patients in a safer 
environment.   
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